Bohui Biotech completed nearly 100 million yuan in Series A+ financing.

36Kr learned that "Bohui Biotech" recently successfully completed a nearly 100 million yuan Series A+ financing round. This round of financing was led by Yizhuang State-owned Investment, followed by Beijing Venture Capital Investment, and the existing shareholder Longpan Investment continued to increase its investment. Since then, the company has completed a Series A financing of over 100 million yuan. This round of financing will be mainly used to accelerate the clinical advancement of core projects and the expansion of pre-clinical pipelines, comprehensively assisting the company in moving towards a new phase of clinical development and internationalization.